Inhibikase Therapeutics, Inc. (IKT) Earnings Call Transcripts
About Inhibikase Therapeutics, Inc.
Inhibikase Therapeutics, Inc. (IKT) is a publicly listed company, within the Health Care sector. It trades on NASDAQ and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 10 calls on record spanning November 15, 2022 to June 27, 2025. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 10 Inhibikase Therapeutics, Inc. earnings call transcripts on record, spanning November 15, 2022 to June 27, 2025. Based on this history, Inhibikase Therapeutics, Inc. reports quarterly. The most recent call on file is dated June 27, 2025. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- IKT
- Exchange
- NASDAQ
- Country
- US
- Sector
- Health Care
- Calls on record
- 10
- First call
- November 15, 2022
- Most recent
- June 27, 2025
- Reporting cadence
- quarterly
| Quarter | Date | |
|---|---|---|
| Shareholder/Analyst Calls | Jun 27, 2025 | Read transcript → |
| Q2 FY2024 | Aug 15, 2024 | Read transcript → |
| Q1 FY2024 | May 16, 2024 | Read transcript → |
| Earnings Calls | Mar 28, 2024 | Read transcript → |
| Q3 FY2023 | Nov 15, 2023 | Read transcript → |
| Q2 FY2023 | Aug 15, 2023 | Read transcript → |
| Q1 FY2023 | May 16, 2023 | Read transcript → |
| Q4 FY2022 | Apr 3, 2023 | Read transcript → |
| Special Calls | Mar 22, 2023 | Read transcript → |
| Q3 FY2022 | Nov 15, 2022 | Read transcript → |